Picture of Clariane SE logo

CLARI Clariane SE Cashflow Statement

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapContrarian

Annual cashflow statement for Clariane SE, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

C2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line12245-80.3-26.99.2
Depreciation
Non-Cash Items231246242250155
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-125-46.9-108-26.569.9
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Other Operating Cash Flow
Cash from Operating Activities8408628049001,072
Capital Expenditures-529-622-484-308-256
Purchase of Fixed Assets
Other Investing Cash Flow Items-296-148-185356394
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Change in Net Investments
Other Investing Cash Flow
Cash from Investing Activities-825-770-67047.7138
Financing Cash Flow Items6.71-215-174-377-344
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities31.4-550-194-1,107-947
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash50.3-465-57.7-159263